-
Mashup Score: 0Positive Margins Post-Prostatectomy: Does Size Matter? - 2 year(s) ago
A systematic review and meta-analysis indicates that larger positive margins after surgical removal of the prostate are prognostic for disease recurrence.
Source: MedscapeCategories: Latest Headlines, SurgeryTweet
-
Mashup Score: 0UTUC Adjuvant Chemotherapy Beneficial in Selected Cases - 2 year(s) ago
Adjuvant chemotherapy prolongs survival among patients with negative surgical margins regardless of number of positive lymph nodes.
Source: Renal and Urology NewsCategories: Latest Headlines, NephrologyTweet-
UTUC Adjuvant Chemotherapy Beneficial in Selected Cases https://t.co/QfGdY1E5se #EAU22
-
-
Mashup Score: 0Prostate Cancer Outcomes After HIFU Characterized - 2 year(s) ago
Patients who underwent HIFU total ablation of the prostate had a 30-month failure-free survival rate similar to that of patients treated with radical prostatectomy, according to investigators.
Source: Renal and Urology NewsCategories: Latest Headlines, UrologyTweet-
Prostate Cancer Outcomes After HIFU Characterized https://t.co/u8HgOKxC9i #pcsm ##EAU22
-
-
Mashup Score: 0VJOncology – The video journal of oncology - 2 year(s) ago
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🖥️ If you missed #EAU22, or want to recap key updates in urology delivered by leading experts, head to https://t.co/ys1d8pDAKO and follow us on @VJOncology to see more exclusive content! @Uroweb #PCSM #Blcsm #kcsm #uroonc #GUsm https://t.co/8h6VvY4M0E
-
-
Mashup Score: 0Positive Margins Post-Prostatectomy: Does Size Matter? - 2 year(s) ago
A systematic review and meta-analysis indicates that larger positive margins after surgical removal of the prostate are prognostic for disease recurrence.
Source: MedscapeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Here's an instance where size DOES indeed matter. #EAU22 #PCSM https://t.co/XaK11hDsgM
-
-
Mashup Score: 5
At the 2022 EAU meeting, Declan Murphy presented the initial results of LuTectomy, a single-arm study of the dosimetry, safety, and potential benefit of 177Lu-PSMA-617 prior to radical prostatectomy. Biochemical recurrence rates remain very high for men undergoing either surgery or radiotherapy for localized prostate cancer and no neoadjuvant strategies have succeeded this far in changing that….
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
#LuTectomy, a single-arm study of the dosimetry, safety, and potential benefit of 177Lu-PSMA-617 prior to radical prostatectomy. @declangmurphy & @RenuEapen @PeterMacCC join @dr_coops @UCSFCancer to discuss progress thus far in the LuTectomy trial > https://t.co/vz0EfDRqU2 #EAU22 https://t.co/NTpe3i0rBz
-
-
Mashup Score: 0Tamsulosin After Shockwave Lithotripsy Ups Stone-Free Rate - 2 year(s) ago
A recent study may support use of tamsulosin as medical expulsion therapy following shockwave lithotripsy.
Source: Renal and Urology NewsCategories: Latest Headlines, UrologyTweet-
Tamsulosin After Shockwave Lithotripsy Ups Stone-Free Rate https://t.co/rxBMQpgj2X #EAU22
-
-
Mashup Score: 0Data Support Trimodal Therapy for Muscle-Invasive Bladder Cancer - 2 year(s) ago
A propensity-score matched comparison revealed no significant difference in oncologic outcomes between radical cystectomy and trimodal therapy.
Source: Renal and Urology NewsCategories: Latest Headlines, UrologyTweet-
Data Support Trimodal Therapy for Muscle-Invasive Bladder Cancer https://t.co/jVOUBxThsO #blcsm #EAU22
-
-
Mashup Score: 0
Cytoreductive partial nephrectomy and robotic radiosurgery appear to have a place in the treatment of metastatic renal cell carcinoma, research findings suggest.
Source: Renal and Urology NewsCategories: Latest Headlines, UrologyTweet-
New Insight Into Surgical Treatment of Metastatic Renal Cell Carcinoma https://t.co/gijT29AYya #kcsm #EAU22
-
-
Mashup Score: 10
EAU 2022 prostate-specific membrane antigen (PSMA) theranostics metastatic castration-resistance prostate cancer (mCRPC), mCRPC therapeutic landscape, treatment paradigm mCRPC, EAU guidelines for mCRPC patients
Source: www.urotoday.comCategories: Latest Headlines, UrologyTweet-
PSMA theranostics and novel approaches to treatment in #mCRPC. Presentation by @CaPsurvivorship @DanaFarber. #EAU22 written coverage by @rksayyid @UofTUrology > https://t.co/EnY9f0uOuN @Uroweb https://t.co/BeZzDQHVnJ
-
Here's an instance where size DOES indeed matter. #EAU22 @Uroweb https://t.co/MW7GO17Ox3